WRK-1 rat mammary tumour cells respond to vasopressin with increased accumulation ofinositol phosphates as well as increased precursor incorporation into phosphatidylinositol. The phorbol ester, phorbol 13-myristate 12-acetate (PMA) inhibits by 80% both inositol phosphate accumulation and increased precursor incorporation. This inhibition is much less evident at early times (2 min) than at later times (25 min).
INTRODUCTION
The phorbol ester tumour promoters have been reported to activate protein kinase C in a variety of systems (Nishizuka, 1984) , as well as to synergize with Ca2+ ionophores in mimicking the activities of a number of Ca2+-mobilizing hormones (Yamanishi et al., 1983; Culty et al., 1984) . On the basis of these findings it has been suggested that tumour-promoter action is mediated by stimulation of protein kinase C, the activation of which constitutes one arm of the phosphoinositide pathway. Paradoxically, however, it has also been reported that phorbol esters inhibit both agonist-induced increases in incorporation of [32P]P, into phosphatidylinositol (Sahai et al., 1982; Smith et al., 1983) as well as accumulation of inositol phosphates (Labarca et al., 1984) . We report here that the same situation applies to vasopressin-induced phosphoinositide metabolism in WRK-1 cells.
MATERIALS AND METHODS
Tissue-culture media, sera, trypsin and Dulbecco's phosphate-buffered saline (without Ca2+ and Mg2+) were supplied by Gibco. Phosphate-free medium was from Flow Laboratories. Insulin was purchased from Eli Lilly Co. Vasopressin was from Calbiochem.
[32P]P1 (carrierfree) was purchased from ICN. myo-[3H]Inositol was from New England Nuclear. Phospholipid standards were from Sigma. Quin 2 AM was from Sigma. Thin-layer plates (IB2-F) were from Baker and organic solvents were purchased from Fisher. Aquasol II was from New England Nuclear. Synthetic OAG was purchased from Serdary.
Cell culture WRK-1 cells were established from a dimethylbenz[a]-anthracene-induced rat mammary tumour as previously described Monaco et al., 1978) .
Growth characteristics and responses to neurohypophysial hormones have also been described (Monaco & Lippman, 1982; Monaco & Woods, 1983) . In brief, cells were grown in monolayer cultures in minimal essential medium containing Earle's salts and supplemented with penicillin (100 units/ml), streptomycin (100,ug/ml), Fungizone (0.25 jug/ml), calf serum (5o/, v/v) and rat serum (2%, v/v were extracted and quantified as previously described (Monaco & Woods, 1983) .
Measurement of 13Hlinositol phosphate accumulation
Cells were plated and grown in [3H]inositol (10 Ci/ml). When confluent, cells were harvested and resuspended in serum-free minimal essential medium containing 10 mM-LiCl. This concentration of Li+ did not effect basal incorporation of precursors into lipids or cell viability. Cells were then incubated at 37°C for 2 or 25 min with the additions indicated.
All samples contained 0.2% DMSO, the solvent used as vehicle for PMA; DMSO at this concentration has no observable effect on WRK-1 cells. At the end of the incubation period, cells were pelleted by centrifugation and extracted with chloroform/methanol/0.1 M-HCI (8:4:3, by vol.). The aqueous layer was dried down in vacuo and the inositol phosphates separated as previously described (Downes & Michell, 1981) .
Vol. 236
Abbreviations used: PMA, phorbol 13-myristate 12-acetate ('TPA'); OAG, oleoylacetylglycerol; DMSO, dimethyl sulphoxide.
Measurement of cytosolic free Ca2+
Cytosolic free Ca2+ concentrations were measured using quin 2 AM as a fluorescent indicator as previously described (Gershengorn & Thaw, 1983 Effect of PMA on vasopressin-induced Ca2+ mobilization The ability of vasopressin to increase the level of intracellular Ca2+ is shown in Fig. 2(a) . Fig. 2(b) illustrates the effect of vasopressin after a 2min preincubation with PMA. No attenuation of the hormone's effect is observed, and PMA alone has no effect. Vasopressin raised intracellular Ca2+ levels from 199 nm to 689 nm in the absence ofPMA and from 156 nm to 783 nm in its presence. However, if cells are preincubated with PMA for 25 min before the addition of hormone, vasopressin-induced mobilization of Ca2+ is strongly inhibited (Fig. 3) . In the absence of PMA, vasopressin increased free Ca2+ concentrations from 186 nm to 1897 nm, whereas after incubation with PMA for 25 min the vasopressin-stimulated value was only 373 nM. Effect of PMA on inositol phosphate accumulation at early times The fact that PMA did not block vasopressin-induced Ca2+ mobilization unless cells were preincubated for 25 min with PMA suggested that hormone-induced inositol phosphate accumulation might also be intact if PMA were only present for a short time. To test this, we measured inositol phosphates after 2 min of stimulation with vasopressin in the presence and absence of simultaneously added PMA. Table 4 illustrates the results of two separate experiments. The effect of PMA seen at this time is markedly less than that seen at 25 min. Effect of OAG on the phosphoinositide cycle
The synthetic diacylglycerol analogue OAG has been shown to stimulate protein kinase C activity in whole cells (Kaibuchi et al., 1983 ) and as such might be expected to have effects similar to those seen with PMA. We tested the ability of OAG to inhibit vasopressin-induced phosphoinositide metabolism. al., 1983) , it has been suggested that activation of this enzyme is the mechanism by which these compounds alter cellular metabolism. Paradoxically, although protein kinase C activation is thought to be a normal component involved in the phosphoinositide pathway of cellular activation by calcium-mobilizing hormones and neurotransmitters, interaction of PMA with cells has been reported to block both the agonist-stimulated breakdown and resynthesis of the phosphoinositides (Sahai et al., 1982; Smith et al., 1983; Labarca et al., 1984) . We report here that such is also the case for vasopressin-sensitive WRK-1 cells. After a sufficient incubation time (25 min) with phorbols, inhibition in the range of 80% is observed; however, at earlier times (2 min) there is no significant interference with the hormone-induced rise in inositol phosphates or in cytosolic Ca2+. Down-regulation of vasopressin receptors is not seen in the presence of PMA, suggesting that the event involved in inhibition occurs subsequent to binding of ligand to receptor, perhaps through inactivation of the receptor coupling mechanism.
Recently, a number of investigators have reported that PMA can antagonize the effects of Ca2+-mobilizing hormones, including fMet-Leu-Phe (Naccache et al., 1985) , a1-adrenergic agonists (Corvera & Garcia-Sainz, 1984; Lynch et al., 1985; Cooper et al., 1985) and thrombin, platelet-activating factor and vasopressin (platelets) (MacIntyre et al., 1985) . Effects of vasopressin on liver have been reported to be unaffected by phorbol esters, except at low concentrations of vasopressin (Cooper et al., 1985; Lynch et al., 1985) . Phorbol esters have minimal effects on vasopressin-induced phosphorylase activity, Ca2+-mobilization or inositol phosphate generation. The results presented here for short-term (2 min) incubations with PMA are in agreement with these findings. At early times, vasopressin activity is unaffected by the addition of tumour promoters; however, if one examines later times (25 min) one sees significant inhibition by these phorbols. The results shown in Table 3 indicate that the phorbols take a longer time to effectively inhibit phosphoinositide breakdown than does vasopressin to stimulate it. Thus either pretreatment for 25 min or simultaneous incubation for 25 min results in inhibition of vasopressin activity. The fact that the phorbols can inhibit the effects of other agonists, such as fMet-Leu-Phe, al-adrenergic compounds and vasopressin (platelets), at early times may indicate either that these substances require longer times in order to activate phosphoinositide metabolism or that the early activity of PMA is powerful enough to obliterate a weaker (than the hormone) effect on phosphoinositide breakdown.
Lastly, OAG (100 ng/ml) was unable to mimic the inhibitory effect of PMA. Cooper et al. (1985) , on the other hand, found that OAG could completely inhibit phenylephrine-induced rises in cytosolic free Ca2 , although much larger concentrations of OAG were required (12-60 ,sg/ml) compared with PMA (10-100 ng/ml). We have no explanation for this discrepancy. We have also found that OAG is incapable of stimulating phosphatidylcholine metabolism in WRK-1 cells, whereas PMA is a potent stimulator (results not shown).
In summary, phorbol ester tumour promoters are potent inhibitors of vasopressin-induced changes in phosphoinositide metabolism if given sufficient time to act. The delay in PMA activity may reflect the time required for the compound to penetrate the cell and reach its site ofactivity. Since we see no difference in the number of vasopressin receptors in the presence of PMA, we suggest that a decrease in the functionality of the receptor, due possibly to increased phosphorylation, as previously described for the insulin receptor (Takayama et al., 1984) may explain the inhibitory effects of PMA on vasopressin activity.
